Cetaphil, the globally trusted dermatologist-recommended brand, launched its Healthy Renew range in India today. The new line caters to consumers seeking anti-ageing solutions that remain gentle on sensitive skin and reduce irritation risk. It combines science-backed ingredients and barrier-supportive technology to address early signs of aging effectively. “Sensitive skin ages differently. Harsh ingredients often worsen irritation,” said Raghavendra Sadashiva, Managing ...
L’Oréal India has launched La Roche-Posay, a dermatologist-recommended skincare brand, to expand its dermo-cosmetics portfolio. The initial product range features 4 key lines Mela B3 Serum, which uses Melasyl™ to reduce dark spots and melasma. Anthelios provides broad-spectrum UVA/UVB protection for sensitive skin. Cicaplast supports skin barrier recovery. Effaclar targets acne-prone skin with specially formulated care. Science-backed skincare La Roche-Posay ...
Galderma released findings from a groundbreaking real-world study in China, showing how lifestyle and environmental factors directly affect sensitive skin. Galderma will present the results at the European Academy of Dermatology and Venereology (EADV) 2025 Congress. The findings highlight a direct biological link between modern urban living and worsening skin health. Rising prevalence of sensitive skin Sensitive skin affects up ...
Sensitive skin is now one of the most common skin concerns, affecting nearly 70 per cent of people worldwide. Sensitive skin cases have increased dramatically in 20 years, raising questions about the impact of modern lifestyles and environmental changes. Galderma has been actively studying this trend through its Global Sensitive Skin Faculty, which is a group of leading dermatology experts. ...
Galderma showcased significant updates across its dermatology portfolio at the 2025 American Academy of Dermatology (AAD) Annual Meeting. The company reinforces its leadership commitment in dermatology innovation with 22 scientific presentations, including two oral e-posters. Nemluvio Nemolizumab (Nemulizumab), Galderma’s treatment for prurigo nodularis and atopic dermatitis, was a key focus at AAD 2025. A new oral presentation showcases Nemluvio’s efficacy ...